In the Boardroom
Refine Search
Biotechnology
Belgian regenerative, protective and reconstructive therapy specialist Cardio3 Biosciences has appointed Warren Sherman as chief medical officer. 23 October 2014
Biotechnology
US rare disease company aTyr Pharma has named John McKew as vice president of research. 22 October 2014
Biotechnology
PDL BioPharma has appointed Danny Hart as vice president of business development. 6 October 2014
Biotechnology
Cancer-focused genetic testing service provider NeoGenomics has appointed Robert Shovlin as chief operating officer. 30 September 2014
Biotechnology
Swedish drug developer Karolinska Development has appointed current board member Klaus Wilgenbus as chief executive on an interim basis, following the departure of Torbjörn Bjerke from the position. 30 September 2014
Biotechnology
Inflammation, oncology and biodefense biopharma company Soligenix has announced the appointment of Rasappa Arumugham as vice president of biopharmaceutical development. 23 September 2014
Biotechnology
Dimension Therapeutics, a US gene therapy company focused on rare diseases, has appointed Annalisa Jenkins as chief executive, who succeeds interim chief executive Thomas Beck. 17 September 2014
Biotechnology
British gene and cell therapy company Oxford BioMedica has appointed Paul Blake as chief development officer. 15 August 2014
Biotechnology
US-based Neurotrope, developers of diagnostic and therapeutic technologies for the treatment of neurodegenerative diseases, has announced the appointment of co-chairmen Charles Ramat and Paul Freiman as co-chief executives on an interim basis. 21 July 2014
Biotechnology
UK-based biotech company Oxford BioTherapeutics, focusing on antibody-drug conjugates in the treatment of cancer, has announced the appointment of Eugen Leo as head of clinical development. 11 July 2014
Biotechnology
Biotechnology firm Retrogenix has announces the appointment of Matthew Britz as North American Business Development Director with immediate effect. 23 June 2014
Biotechnology
US biotech firm Dendreon revealed last evening that John Johnson plans to step down as president and chief executive officer for personal reasons. 10 June 2014
Biotechnology
UK-based monoclonal antibody biopharmaceutical company Kymab has announced the appointment of Steve Arkinstall as Chief Scientific Officer and Nigel Clark as Vice President and Head of Business Development. 3 June 2014
Biotechnology
UK-based drug discovery and development company Summit has announced the appointment of Leopoldo Zambeletti as a Non-Executive Director. 30 May 2014
Biotechnology
French drugmaker Domain Therapeutics has announced the nomination of Youssef Bennani to the board of directors. 28 May 2014
Biotechnology
Swedish Orphan Biovitrum has announced the appointment of Kirsti Gjellan as Senior Vice President Manufacturing Operations. 27 May 2014
Biotechnology
US biotech company Celgene Corp (Nasdaq: CELG) has announced organizational changes to its leadership team, effective August 1, 2014. 23 May 2014
Biotechnology
US-based biopharmaceutical company Nektar Therapeutics (Nasdaq: NKTR) has announced that Ivan Gergel will serve as the Company's new Senior Vice President, Drug Development & Chief Medical Officer effective immediately. 19 May 2014
Biotechnology
US biotech firm Amgen has announced the appointment of Steven Galson to the position of senior vice president, Global Regulatory Affairs and Safety, effective May 19. 14 May 2014
Biotechnology
German biotech company Proteros has announced significant changes in its management team. 12 May 2014
Biotechnology
US biotech Paragon Therapeutics yesterday revealed that biotech industry veteran Susanna High has been appointed as chief executive (CEO). In this newly-created role, Ms High will lead the team’s continued efforts to propel the development of a pipeline of transformative therapies and accelerate their potential impact. 22 November 2024
Biotechnology
US biotech major Amgen has announced that Dr Howard Chang will join the company as senior vice president of research, effective December 16, 2024. 21 November 2024
Biotechnology
Mirai Bio has announced the appointment of Jens Vogel as the company’s president and chief operating officer (COO). 20 November 2024
Biotechnology
Aclaris Therapeutics has announced an exclusive licensing agreement with Biosion for broad rights to two new antibodies. 19 November 2024
Biotechnology
Privately-held US biotech Georgiamune has announced the appointment of Mark Avagliano as chief business officer (CBO). 19 November 2024
Biotechnology
Belgian biotech start-up ExeVir Bio says it has appointed Michael Garrett as its new chief executive (CEO), effective 1 December 2024. 18 November 2024
Biotechnology
ALX Oncology Holdings, a Californian immuno-oncology company, has announced the appointment of Alan Sandler as chief medical officer (CMO). 14 November 2024
Biotechnology
VarmX, a Dutch biotech developing innovative approaches for the bypass of direct oral anticoagulants targeting activated factor Xa (FXa DOACs) and inherited coagulation disorders, has appointed industry veteran John Glasspool (pictured, above) as chief executive. 12 November 2024
Biotechnology
French biotech DiogenX, which is focused on regenerating insulin-producing beta cells for the treatment of diabetes, today announces the appointment of Dr Klara Owen as chief medical officer. 12 November 2024
Biotechnology
Rubedo Life Sciences, a US biopharma developing first-in-class therapies targeting senescent cells which drive age-related diseases, has announced the appointment of Frederick C Beddingfield III, as chief executive officer and board director. 11 November 2024
Biotechnology
US clinical-stage drug developer Acumen Pharmaceuticals has appointed Amy Schacterle as chief regulatory officer and head of quality, reporting to Jim Doherty, president and chief development officer at Acumen. 7 November 2024
Biotechnology
Memo Therapeutics, a privately-held Swiss biotech company translating unique responses into superior medicines to treat viral infections and cancer, has appointed a new chief development officer (CDO). 4 November 2024
Biotechnology
Netherlands-based Tessellate BIO, a pre-clinical stage biotech with a focus on novel synthetic lethality approaches, today announced the appointment of Dr Lara Boyd as chief business officer. 4 November 2024
Biotechnology
US biotech major Biogen revealed it has appointed Daniel Quirk as chief medical officer and head of medical affairs. 29 October 2024
Biotechnology
AAVantgarde has announced the appointment of Lauren Kaskiel as chief business officer (CBO). 22 October 2024
Biotechnology
Denmark’s Commit Biologics, a specialist in the activation of the complement system to treat cancer and autoimmune disease, has announced the appointment of Mikkel Wandahl Pedersen as chief scientific officer (CSO). 15 October 2024
Biotechnology
French biotech Innate Pharma has appointed Jonathan Dickinson as its new chief executive (CEO) and chairman of the executive board, effective November 1, 2024. 14 October 2024
Biotechnology
Turnstone Biologics has announced a major restructuring of its operations, cutting its workforce by approximately 60%. 14 October 2024
Biotechnology
Calluna Pharma, a biotech focused on treating inflammatory and fibrotic diseases, has appointed Mark Gaffney as its new chief executive. 9 October 2024
Biotechnology
Privately-held UK biotech Curve Therapeutics has announced the appointment of Rab Prinjha as chief research and development (R&D) officer. 9 October 2024
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze